Fina BioSolutions Revenue and Competitors
Estimated Revenue & Valuation
- Fina BioSolutions's estimated annual revenue is currently $1.7M per year.
- Fina BioSolutions's estimated revenue per employee is $155,000
Employee Data
- Fina BioSolutions has 11 Employees.
- Fina BioSolutions grew their employee count by 10% last year.
Fina BioSolutions's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and Owner | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | Director Molecular Biology and Protein Purification | Reveal Email/Phone |
4 | Research Chemist | Reveal Email/Phone |
5 | Associate Researcher | Reveal Email/Phone |
Fina BioSolutions Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Fina BioSolutions?
Fina Biosolutions LLC is a privately held research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for prevention of life-threatening diseases. Fina has patented novel techniques to conjugate, purify, and manufacture conjugates using its proprietary chemistry to create complex conjugate vaccines. The technology is currently licensed by leading vaccine manufacturers in both Europe and Asia, including GlaxoSmithKline for marketed vaccines Synflorixâ„¢ Menitorixâ„¢, Nimenrixâ„¢, The Serum Institute of India Ltd., The Chengdu Institute of Biological Products and others. Fina Bosolutions also manufactures E. coli expressed CRM197 conjugate vaccine carrier portein. Fina BioSolutions also develops polymer based diagnostic reagents, amino dextran, and antibody dextran conjugates.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Rockville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 11 | 10% | N/A |
#2 | $0.5M | 11 | -8% | N/A |
#3 | $1M | 11 | 10% | N/A |
#4 | $1.7M | 11 | 22% | N/A |
#5 | $1M | 11 | 22% | N/A |